1. Home
  2. BSVN vs RLMD Comparison

BSVN vs RLMD Comparison

Compare BSVN & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp.

BSVN

Bank7 Corp.

HOLD

Current Price

$58.63

Market Cap

531.3M

Sector

Finance

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.29

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSVN
RLMD
Founded
2004
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
531.3M
461.9M
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
BSVN
RLMD
Price
$58.63
$3.29
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
★ $63.33
$10.75
AVG Volume (30 Days)
34.4K
★ 1.4M
Earning Date
10-15-2026
11-12-2026
Dividend Yield
★ 2.04%
N/A
EPS Growth
N/A
★ 45.28
EPS
★ 2.12
N/A
Revenue
N/A
★ $13,070.00
Revenue This Year
$10.97
N/A
Revenue Next Year
$54.28
N/A
P/E Ratio
$27.71
★ N/A
Revenue Growth
N/A
★ 154.83
52 Week Low
$38.29
$2.15
52 Week High
$59.04
$8.00

Technical Indicators

Market Signals
Indicator
BSVN
RLMD
Relative Strength Index (RSI) 69.33 39.10
Support Level $53.85 $3.13
Resistance Level N/A $3.55
Average True Range (ATR) 1.08 0.21
MACD 0.28 0.03
Stochastic Oscillator 99.34 39.57

Price Performance

Historical Comparison
BSVN
RLMD

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: